Safety and Efficacy of Regorafenib in Patients With Treatment-Refractory Metastatic Colorectal Cancer in Turkey: The Single-Arm, Open-Label REGARD Study

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2018-027665
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Angiogenesis Genotyping and Clinical Outcome During Regorafenib Treatment in Metastatic Colorectal Cancer Patients

Scientific Reports
Multidisciplinary
2016English

The Cost–Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)

Journal of the Peripheral Nervous System
MedicineNeuroscienceNeurology
2013English

A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2019English

Trial Design of Phase IIIb, Open-Label, Single Arm Study to Evaluate Efficacy and Safety of Pasireotide LAR in Patients With Inadequately-Controlled Acromegaly Despite Treatment With First-Generation Somatostatin Analogues

Endocrine Abstracts
2015English

Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Thyroid Dysfunction and Ultrasonography Features in Patients With Metastatic Colorectal Cancer Treated With Regorafenib: Preliminary Results From a Single Centre Prospective Cohort Study

Endocrine Abstracts
2016English

Efficacy and Safety of TAS-116, an Oral Inhibitor of Heat Shock Protein 90, in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumour Refractory to Imatinib, Sunitinib and Regorafenib: A Phase II, Single-Arm Trial

European Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy